A large multi-centre case-control study of gastric cancer (GC) was recently conducted in high and low-risk areas in Italy to investigate reasons for the wide regional differences in GC mortality. The study design and protocol have been published elsewhere (Buiatti et al., 1989a) . Briefly, the casecontrol study involved seven centres grouped into four areas, two with high (1: Forli/Cremona/Imola and 2: Firenze/Siena) and two with low (3: Genova and 4: Cagliari) death rates for GC. All patients with histologically confirmed GC first diagnosed between June 1985 and December 1987 among residents aged 75 or less in the study areas were eligible as cases and sought for interview.
Pathologists in seven centres provided histologic confirmation for the 1016 newly diagnosed GC case included in the analysis, and classified each case according to histologic type. To evaluate the reproducibility of histologic classifications across centres, a structured panel review of cases was carried out. This paper presents the results of the panel review, assessing inter and intra-observer variability in the histologic classification of GC. This background information is valuable for the evaluation of risk factors according to GC cell types.
Classification systems
The classification of GC is a complex and difficult task, primarily because different histologic features often coexist in the same tumour. Among the classification systems, the most widely used are those proposed by Lauren, Ming and the World Health Organization (WHO).
Lauren's classification divides GC into two major types: intestinal and diffuse (Lauren, 1965 The WHO classification is based on morphological features (Oota & Sobin, 1977 The pathologists were asked to define each of the 100 surgical specimens as early gastric cancer (EGC) or AGC and to classify them according to the Lauren, Ming and WHO classifications (using only AGCs for the Ming classification). For the Ming classification, a 'mixed' category was introduced to allow classification of specimens in which the two patterns of growth were equally represented. For the WHO classification, panel members were allowed to report more than a single type. The pathologists then independently examined the 100 biopsy specimens, using only the Lauren system to classify histology.
Analysis
The diagnoses of each pathologist were compared to those of each of the other members of the panel. No attempt was made to define a 'true' diagnosis or a consensus for an individual specimen. As a measure of agreement between the 15 possible pairs of observers, the kappa statistic was used (Fleiss, 1981) . The kappa does not require any assumption concerning the correct diagnosis and includes a correction for the amount of agreement which would be expected by chance alone. Values of kappa near zero indicate chance agreement only, while values near the maximum of 1 indicate perfect agreement. Using the surgical specimens, comparability was measured across three Lauren categories (intestinal, diffuse, and mixed + unclassified), three Ming categories (expanding, infiltrative and mixed), and four combined WHO categories (tubular, papillary and mucinous adenocarcinomas; signetring adenocarcinoma; undifferentiated carcinoma; and other types). Considering the diagnosis based on surgical specimens as the 'true' diagnosis or standard, the sensitivity and specificity of each pathologist's diagnoses of the biopsy specimens were estimated for the main Lauren histologic types.
A measure of intra-observer variability, which was not provided by the panel review (no material was recirculated during the meeting), was estimated for one member of the panel (S.B.), who originally diagnosed all specimens from Florence. At the end of the study S.B. independently reclassified these specimens and those from other centres using the Lauren system.
Results
The distribution of histological diagnoses of the surgical specimens according to the Lauren, Ming and WHO classification systems is shown for each pathologist in Table  I . Using the Lauren system, the relative frequencies of intestinal type cancers ranged from 54-72%, while those of the diffuse type varied from 10-31%. The pathologists judged 80-88% of the tumours to be AGC. Among these, from 44-65% were called expanding type and 25-47% were infiltrative using the Ming classification. The dominant histologic type in the WHO system was adenocarcinoma (tubular/papillary/mucinous), accounting for 55-74% of the diagnoses.
Concordance of diagnoses for all 15 the concordance in diagnoses, the comparison of Lauren histologies for pathologists A and C.
For the Ming system, agreement between pairs of pathologists was not quite as high, ranging from 57-73%, with kappas from 0.31-0.55 (median 0.41). For the WHO system (with four combined categories), agreement ranged from 68-79% with kappas from 0.34-0.64 (median 0.51). Kappa values (for all three systems) were significantly (P<0.01) different from zero. Exact agreement between pairs of pathologists in diagnosing EGC vs AGC ranged from 87-96%, with kappas from 0.51-0.86 (median 0.76).
Comparisons of the Lauren diagnoses in the surgical vs the biopsy specimens revealed exact agreement ranging from 65% for one pathologist to 75% for another, with kappas ranging from 0.33-0.51. There were no consistent patterns in the types of disagreement, with the percentages of intestinal, diffuse and mixed types about the same whether from a surgical specimen or biopsy. The sensitivities of the diagnoses based on endoscopy ranged from 77-85% for detecting intestinal types, 29-69% for diffuse types, and 0-56% for mixed types. The rate of false positives of the biopsy diagnoses ranged from 13-31% for the intestinal type, 30-50% for the diffuse type, and 59-100% for the mixed type. The rate of false negatives of the biopsy diagnoses ranged from 24-45% for the intestinal type, 5-16% for the diffuse type, and 8-17% for mixed type. Table III shows these levels of agreement for reader C.
Intra-observer variability was assessed for one pathologist (S.B.). Among the 805 GC cases reviewed, 55% were classified as intestinal, 23% as diffuse, 7% as mixed, and 15% as unclassified according to Lauren. For 370 of the GC specimens, S.B. made the original diagnosis prior to the panel review. Concordance between the two repeat readings was extremely high (95%) for these specimens, with a kappa of 0.91 (Table IV) . In contrast, for the remaining 435 GC specimens, 66% (kappa 0.39) of the diagnoses by S.B. agreed with those of the original diagnoses made at the other centres.
Discussion
Reproducibility of histologic classification in a multi-centre epidemiologic study is of special concern when major hypotheses are linked to particular histologic types, as is the case for GC. Several studied suggest that risk factors for GC may vary by cell type, with the intestinal type showing substantial geographic and demographic variation and suspected to be more closely linked to environmental exposures (Nomura, 1982) . The present investigation shows that whereas intraobserver repeatability was excellent, there was a lower rate of agreement between pathologists in specifying histologic types by the widely used Lauren classification, with diagnoses between pairs of pathologists being concordant about 70-80% of the time. Utilising either the Ming or WHO classification systems did not reduce the inter-observer variability.
Our panel review also showed that histologic diagnoses based on surgical vs biopsy specimens from the same subjects also agreed about 65-75% of the time. Hence, variations in the availability of surgical compared to biopsy material across centres could also influence the classification of GC. No systematic differences between diagnoses based on surgery vs endoscopy were evident, however, so using diagnoses based on either procedure should not differentially bias results. A previous review of 297 GC patients in Florence reached a similar conclusion (Amorosi et al., 1988) .
As a preliminary step to using Ming's classification, all surgical specimens were classified as EGC or AGC. Although the pathologists generally tended to agree, the distinctions between early and advanced cancers were not always clear, and levels of concordance were somewhat lower than expected.
As a result of inter-observer discrepancies, it was decided that the final reclassification of all histologic material available in the multi-centre study should be made by a single pathologist. This approach was felt to be necessary to avoid variability between centres which could distort or obscure the detection of GC risks by histologic type.
